Evidence map›Paper›PMID 29603867›Full record

ArticleAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics2018

Delineating the psychiatric and behavioral phenotype of recurrent 2q13 deletions and duplications.

Kate Wolfe, Andrew McQuillin, Viola Alesi, Elise Boudry Labis, Peter Cutajar, Bruno Dallapiccola, Maria Lisa Dentici, Anne Dieux-Coeslier, Benedicte Duban-Bedu, Tina Duelund Hjortshøj and 18 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A cross-comparison of cognitive ability across 8 genomic disorders.Current opinion in genetics & development · 2021
    Review
  9. Article
  10. Article
  11. Delineating the psychiatric and behavioral phenotype of recurrent 2q13 deletions and duplications.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 7 countries.

Kate WolfeMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, United Kingdom.ORCID 0000-0003-0044-5379
Andrew McQuillinMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, United Kingdom.
Viola AlesiMedical Genetics Unit, Medical Genetics Laboratory, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
Elise Boudry LabisInstitut de génétique médicale, CHU Lille, Lille, France.
Peter CutajarNottinghamshire Healthcare NHS Foundation Trust, Nottingham, United Kingdom.
Bruno DallapiccolaMedical Genetics Unit, Medical Genetics Laboratory, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
Maria Lisa DenticiMedical Genetics Unit, Medical Genetics Laboratory, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
Anne Dieux-CoeslierService de génétique clinique, CHU Lille, Lille, France.
Benedicte Duban-BeduCentre de génétique chromosomique, Hopital Saint-Vincent de Paul, Lille, France.
Tina Duelund HjortshøjKennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Himanshu GoelHunter Genetics, Waratah, New South Wales, Australia.
Sara LoddoMedical Genetics Unit, Medical Genetics Laboratory, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
Deborah MorroghNorth East Thames Regional Genetics Service Laboratory, London, United Kingdom.
Anne-Laure Mosca-BoidronService de Cytogénétique, Plateau technique de Biologie, CHU Dijon, France.
Antonio NovelliMedical Genetics Unit, Medical Genetics Laboratory, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
Laurence Olivier-FaivreCentre de référence Anomalies du développement et Syndromes malformatifs, FHU TRANSLAD, CHU Dijon, France.ORCID 0000-0001-9770-444X
Jennifer ParkerNorth East Thames Regional Genetics Service Laboratory, London, United Kingdom.
Michael J ParkerSheffield Clinical Genetics Service, Sheffield Children's Hospital, Western Bank, Sheffield, United Kingdom.
Christine PatchKing's College London, Florence Nightingale Faculty of Nursing and Midwifery, London, United Kingdom.
Anna L PellingInformation Officer, Unique - The Rare Chromosome Disorder Support Group (www.rarechromo.org), The Stables, Station Road West, Oxted, Surrey, United Kingdom.
Thomas SmolInstitut de génétique médicale, CHU Lille, Lille, France.
Zeynep TümerKennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Olivier VanakkerCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Arie van HaeringenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Clémence VanlerbergheService de génétique clinique, CHU Lille, Lille, France.
Andre StrydomMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, United Kingdom.
David SkuseBehavioural and Brain Sciences Unit, Institute of Child Health, University College London, London, United Kingdom.
Nick BassMolecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, United Kingdom.
Bambino Gesù Children's Hospital · ITMRC Laboratory for Molecular Cell Biology · GBUniversité de Lille · FRCopenhagen University Hospital · DKKing's College London · GBWessex Regional Genetics Laboratory · GBCentre Hospitalier Universitaire de Lille · FRGhent University Hospital · BEHôpital Saint-Vincent-de-Paul · FRHunter Genetics · AULeiden University Medical Center · NLNottinghamshire Healthcare NHS Foundation Trust · GBPhysiogenex (France) · FRSheffield Children's Hospital · GBThe Stables · GBUniversity College London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Recurrent deletions and duplications at the 2q13 locus have been associated with developmental delay (DD) and dysmorphisms. We aimed to undertake detailed clinical characterization of individuals with 2q13 copy number variations (CNVs), with a focus on behavioral and psychiatric phenotypes. Participants were recruited via the Unique chromosomal disorder support group, U.K. National Health Service Regional Genetics Centres, and the DatabasE of genomiC varIation and Phenotype in Humans using Ensembl Resources (DECIPHER) database. A review of published 2q13 patient case reports was undertaken to enable combined phenotypic analysis. We present a new case series of 2q13 CNV carriers (21 deletion, 4 duplication) and the largest ever combined analysis with data from published studies, making a total of 54 deletion and 23 duplication carriers. DD/intellectual disabilities was identified in the majority of carriers (79% deletion, 70% duplication), although in the new cases 52% had an IQ in the borderline or normal range. Despite the median age of the new cases being only 9 years, 64% had a clinical psychiatric diagnosis. Combined analysis found attention deficit hyperactivity disorder (ADHD) to be the most frequent diagnosis (48% deletion, 60% duplication), followed by autism spectrum disorders (33% deletion, 17% duplication). Aggressive (33%) and self-injurious behaviors (33%) were also identified in the new cases. CNVs at 2q13 are typically associated with DD with mildly impaired intelligence, and a high rate of childhood psychiatric diagnoses-particularly ADHD. We have further characterized the clinical phenotype related to imbalances of the 2q13 region and identified it as a region of interest for the neurobiological investigation of ADHD.

Indexed as

AdolescentAdultChildChild, PreschoolChromosome AberrationsChromosome DeletionChromosome DuplicationChromosomes, Human, Pair 2Developmental DisabilitiesDNA Copy Number VariationsFemaleGene DuplicationHumansIntellectual DisabilityMaleMental Disordersattention deficit hyperactivity disorderautism spectrum disorderscopy number variantsdevelopmental delayintellectual disabilities

Identifiers

PMID29603867
PMCPMC6001478
OpenAlexW2794496825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.